PepGen Inc.PEPGNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank48
5Y CAGR-49.9%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-49.9%/yr
Long-term compound
Percentile
P48
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 8.45% |
| Q3 2025 | -28.86% |
| Q2 2025 | -27.53% |
| Q1 2025 | 36.58% |
| Q4 2024 | 4.85% |
| Q3 2024 | -29.29% |
| Q2 2024 | 74.58% |
| Q1 2024 | -9.97% |
| Q4 2023 | -22.37% |
| Q3 2023 | 21.35% |
| Q2 2023 | 17.87% |
| Q1 2023 | 9.07% |
| Q4 2022 | -17.53% |
| Q3 2022 | 12.11% |
| Q2 2022 | 33.00% |
| Q1 2022 | 14.62% |
| Q4 2021 | 63.53% |
| Q3 2021 | 77.61% |
| Q2 2021 | -41.84% |
| Q1 2021 | 1198.12% |
| Q4 2020 | 267.24% |
| Q3 2020 | -45.54% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |